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Summary  
Human birth weight is subject to stabilizing selection.  Large babies are at 
risk of obstetric complications such as obstructed labour, which endangers 15 
both mother and child. Small babies are also at risk with reduced survival. 
Fetal growth requires remodeling of maternal spiral arteries to provide an 
adequate maternal blood supply to the placenta. This arterial 
transformation is achieved by placental trophoblast cells, which invade into 
the uterine wall. Under invasion is associated with fetal growth restriction; 20 
but if invasion is excessive large babies can result. A growing body of 
evidence suggests that this process is controlled by interactions between KIR 
receptors expressed on maternal uterine NK cells (uNK) and their 
corresponding HLA-C ligands on invading trophoblast. Mothers with the KIR 
AA genotype and a fetus with a paternal HLA-C2 allele tend to have small 25 
babies, because this combination inhibits cytokine secretion by uNK. 
Mothers with the activating KIR2DS1 gene and an HLA-C2 fetus are more 
likely to have large babies. When KIR2DS1 binds to HLA-C2 this increases 
secretion of cytokines that enhance trophoblast invasion. We conclude that 
specific combinations of the highly polymorphic gene systems, KIR and HLA-30 
C, contribute to successful reproduction by maintaining birth weight 
between two extremes.  
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Introduction 
The role of the immune system in the development of both the brain and 50 
the placenta during the evolution of modern humans may not be 
immediately obvious. This paper reviews the part played by the immune 
system at the moment in human life history when brain size and pelvic 
anatomy interact in a way that is critical to success and failure of pregnancy. 
Human brains are now so large that it is an extremely tight fit for them to 55 
squeeze through the pelvis.  Indeed, babies often do get stuck during the 
passage through the birth canal resulting in obstructed labour. It is not just 
pregnancies with very large babies where mothers and their babies are at 
risk of morbidity and mortality.  At the opposite end of the spectrum when 
babies are too small this can have equally damaging consequences. Karn and 60 
Penrose first noted this selective pressure at the extremes of the birth 
weight spectrum in the 1930s but it was Bodmer who pointed out that 
human birth weight is a prime example of balancing or stabilizing selection 
(1,2).  Although death of babies is now less frequent due to advances in 
neonatal medicine, there is still considerable morbidity. Our recent study in 65 
Norway shows babies were most frequently admitted to the neonatal ward 
when they were born at the extremes of the birth weight spectrum (3). This 
suggests there is still strong selective pressure to maintain human birth 
weight between these two extremes. This situation, encapsulated in the 
notion of the Obstetric Dilemma, is a particular problem for humans. 70 
 
Placentation and fetal growth 
Growth of the fetus and size at birth must depend on the delivery of 
sufficient nutrients and oxygen to the placenta.  The supply line in the 
uterus is via the maternal arteries supplying blood to the placenta – so-75 
called spiral arteries.  In humans these are structurally transformed during 
early pregnancy to allow blood flow to increase about 100-fold (4).  Arterial 
transformation depends on an unusual process during placentation, whereby 
fetal trophoblast cells from the placenta infiltrate into the uterine wall, 
home to the arteries and destroy the smooth muscle media. As a result of 80 
this trophoblast modification, the arteries become conduits capable of high 
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 4 
conductance at low pressure with a reduction in velocity of the blood 
entering the placenta.  Terminal dilatation of the arteries results in a 
further reduction in the flow rate into the intervillous space. This permits 
adequate time for gas exchange, especially towards the end of the 85 
pregnancy when fetal demands are highest.  When there is failure of arterial 
conversion by trophoblast, then arterial blood will jet into the intervillous 
space from the non-transformed arteries causing damage to the villous tree 
(Figure 1). Transport of oxygen and nutrients to the fetus is reduced and 
this manifests as fetal growth restriction (FGR). In more severe cases the 90 
mother may develop pre-eclampsia, a systemic syndrome that occurs when 
the placenta bec mes stressed as a result of the reduced blood flow (5). 
Soluble factors released from the stressed placenta can trigger an 
inflammatory condition with diverse clinical manifestations. These include 
oedema, proteinuria and high blood pressure and can progress to eclampsia 95 
and maternal death.  This is one of the principal reasons for clinical 
problems in both mothers and babies in pregnancies with very low birth 
weights.  There are other clinical conditions besides pre-eclampsia and FGR 
resulting from defective placentation. Known collectively as the Great 
Obstetric Syndromes (GOS), they include unexplained stillbirth, placental 100 
abruption and preterm labour (6).   
 
The Obstetric Dilemma 
Very large babies (>~4kg) represent the other extreme of the birth weight 
spectrum and these pregnancies are also at risk of clinical problems due to 105 
the difficulty of the passage of their head through the pelvis.  Fetal 
obstruction results in prolonged labour, fetal death from asphyxia, soft 
tissue damage to pelvic organs and post-partum haemorrhage (7). 
Estimation of placental size by sonography shows that, similar to the GOS, 
the origins of macrosomia are present early in gestation (8). The risk of 110 
cephalopelvic disproportion has arisen because of the anatomical 
adaptations necessary for efficient bipedalism. These resulted in narrowing 
of the birth canal, imposing considerable constraints during parturition that 
are characteristic of modern humans even in comparison with neandertals 
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(9).  The human head followed by the shoulders needs to rotate to fit the 115 
three planes of the pelvis that all have different shapes and orientations 
unlike other primates (10).  
 
The combination of a narrow birth canal and the enlarged brain means that 
the Obstetric Dilemma is a particular problem for humans. Fetal growth in 120 
utero depends on development of a good maternal blood supply to the 
placenta that requires modification of the uterine spiral arteries. 
Trophoblast cells from the placenta invade deeply into the stroma to effect 
arterial conversion. The extravillous trophoblast cells (EVT) encircle the 
arteries and then cause direct destruction of the smooth muscle of the 125 
arterial wall with complete loss of vasoconstriction. In contrast, trophoblast 
invasion is much more limited in extent in Old World monkeys where 
trophoblast cells only move down the inside of the arteries to replace the 
endothelium and functionally modify the media (11,12). Amongst primates, 
deep trophoblast invasion through the decidua and into the inner 130 
myometrium is characteristic of human placentation, probably as a 
consequence of the increased blood supply needed to support the in utero 
development of the large brain. Indeed, brain development continues for 
some years after birth in humans (13). Thus, the extent of trophoblast 
invasion has a critical effect on fetal access to maternal oxygen and 135 
nutrients. Under-invasion is associated with GOS such as FGR and pre-
eclampsia, a condition only occurring in humans; over-invasion can result in 
obstructed labour due to the large fetus. A consequence of the balancing 
selection operating to prevent obstructed labour and the birth weight from 
being too large is the persistence of pregnancies with pre-eclampsia and 140 
fetal growth restriction in all populations. The Obstetric Dilemma means 
that the birth weight must therefore be kept closely between the two 
dangerous extremes.  
 
 145 
Regulation of placentation by the decidual immune system 
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Because trophoblast transformation of the arteries affects the growth and 
development of the fetus and placenta, there is much interest in how 
trophoblast invasion is controlled and thus how the supply line to the fetus 
is regulated. In vivo and in vitro observations show that human trophoblast 150 
cells are inherently highly invasive and can penetrate right through the wall 
of the uterus - unless they are controlled.  This is seen, for example, after a 
caesarian section if the placenta implants on the scar in a subsequent 
pregnancy.  Because the mucosal lining of the uterus (decidua) is missing at 
the site of the scar, trophoblast invasion proceeds unchecked, a condition 155 
known as placenta percreta, which can lead to uterine rupture (14).   The 
same behaviour occurs in ectopic pregnancy where implantation occurs in 
the fallopian tube, which also lacks decidua. This suggests decidual tissue 
must be essential for regulation of trophoblast invasion. 
 160 
To understand how decidua regulates placentation we have focused on the 
decidual immune system (15,16). Hints that the immune system was 
involved came initially from studying the epidemiology of pre-eclampsia (17).  
Classically, this is a disease of first pregnancies, giving rise to the idea that 
women became ‘immune’ afterwards.  Change of male partners after a 165 
normal first pregnancy can trigger the condition; conversely women who 
have already had pre-eclampsia may then be protected when they have a 
baby with a new partner (18). These features, memory and specificity are 
characteristic of the immune system.  The familial and genetic contribution 
from the mother is well established, but, importantly, several studies have 170 
also shown that there is a paternal contribution to both pre-eclampsia and 
birth weight (19,20,21).  There is therefore circumstantial evidence that 
interactions between maternal and fetal immune system genes may 
determine successful pregnancy outcome. 
 175 
There are two sites where fetal cells are in direct contact with maternal 
immune cells. Placental villi are covered by syncytiotrophoblast and present 
a large surface area in contact with maternal blood. Intermingling of 
maternal and fetal cells also occurs in the uterus at the site of placental 
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attachment where EVT invade into decidua Figure 1). A territorial boundary 180 
must be defined here between two individuals. Because of the need to 
regulate the blood flow to the placenta and thus the birth weight, this 
boundary needs to be established in the right place. If the placenta (fetus) 
is too intrusive, the mother is at risk of uterine rupture and death. If 
trophoblast invasion is not far enough, spiral arteries are not sufficiently 185 
transformed, the blood flow to placenta is reduced, fetal growth is 
compromised and the mother is at risk of pre-eclampsia.  There is growing 
evidence for the role of the decidual immune system in the subtle 
delineation of this uterine maternal/fetal interface. Because these two 
individuals are genetically different, the invading trophoblast cells will 190 
express molecules encoded by paternal genes meaning that, in 
immunological terms, the fetus is ‘non-self’ to the mother.  How do 
maternal immune cells recognize and respond to the fetal trophoblast cells 
in the decidua, and do these interactions regulate trophoblast invasion? 
 195 
T cells and allorecognition in pregnancy 
T cells recognise antigenic peptides presented by MHC molecules. These 
genes were originally discovered by Peter Medawar as the gene system 
whose products determine rejection or acceptance of transplants (22). 
Unlike somatic cells, syncytiotrophoblast lacks expression of both MHC class 200 
I and class II molecules, so cannot be recognized by T cells.  However 
maternal T cell responses against fetal alloantigens do occur during 
pregnancy, generating fetal-specific T cells and humoral responses. (23). 
During pregnancy, temporary breaks in the synciotrophoblast layer can 
permit fetal cells to enter the maternal circulation. It is likely that these 205 
deported cells give rise to most of the fetal antigen-specific responses that 
have been described in T cells in maternal blood such as that to male HY 
minor histocompatibility antigen (24). There is no evidence that any of 
these responses can directly affect syncytiotrophoblast.  
 210 
EVT in the decidua also express an unusual MHC profile: they lack class II 
expression and do not express the HLA-A or –B molecules normally found on 
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all somatic cells (25). Instead EVT express classical HLA-C as well as non-
classical molecules, HLA-E and –G. The latter two are essentially 
monomorphic in human populations so will not vary from pregnancy to 215 
pregnancy (25). Since most T cells are restricted to recognize self HLA-A or-
B molecules in association with a non-self peptide, the unusual MHC profile 
of EVT means that only HLA-C restricted T cells are capable of directly 
recognizing EVT in the decidua.  A recent study has shown that in HLA-C 
mismatched pregnancies there are decidual T cells present that can 220 
recognize fetal HLA-C when stimulated with fetal cord blood. These are not 
present in HLA-C matched pregnancies. HLA-C mismatched pregnancies 
were also associated with an increase in CD4+CD25bright regulatory T cells 
(Tregs) in the decidua (26). Tregs represent a subset of CD4+ T cells that are 
act to suppress immune responses against self-antigens. They are 225 
characterised by expression of the transcription factor Foxp3 (27). However 
since EVT does not express MHC class II, these CD4+ Tregs presumably 
recognize fetal HLA-C through indirect allo-recognition via presentation of 
HLA-C peptides on maternal antigen presenting cells (APC).  To date there is 
no evidence that T cells are present in human decidua that can directly 230 
recognize fetal alloantigens presented by HLA-C on trophoblast. However 
decidual Tregs are generated in HLA-C mismatched pregnancies and these 
may contribute to generation of a tolerogenic environment in the decidua.  
 
Although there are significant differences in placental anatomy and 235 
trophoblast MHC expression compared to humans, elegant experiments 
possible in mice have given broadly similar results to those seen in humans. 
T cells specific for paternal antigens are generated in allogeneic matings, 
but do not lead to pregnancy failure in normal pregnancies (28). Adoptive 
transfer of CD8+ T cells specific for H2-Kb, to H2-Kb negative females 240 
carrying H2-Kb positive pups, did not result in pregnancy failure even though 
H2-Kbis expressed on trophoblast (29,30). However expansion of Tregs is 
seen during both syngeneic and allogeneic pregnancies and depletion of 
Tregs during pregnancy results in fetal resorption only in allogeneic matings 
(31). Tregs appear to play an important role in preventing rejection of 245 
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allogeneic pregnancies but the exact mechanism is unclear. In both mouse 
and humans multiple other mechanisms have been described that contribute 
to T cell tolerance. These include: ‘trapping’ of APCs within the decidua 
reducing migration to regional lymph nodes, reduced T cell entry into 
decidua by silencing of chemokine expression, stimulation of APCs by HLA-G 250 
to induce a tolerogenic cytokine secretion and many others (reviewed in 
32,16). However, in humans there is no evidence that T cell dependent 
adaptive responses to fetal antigens, either systemically or in decidua, are 
involved in damaging placental cells or causing pregnancy failure.  
 255 
Uterine NK cells and recognition of trophoblast HLA class I molecules 
T cells comprise only 5-20% of decidual leukocytes. The overwhelming 
majority of leukocytes in the decidua are uterine Natural Killer cells (uNK).   
These are uniquely found in the endometrium during the luteal phase of the 
menstrual cycle when implantation occurs, and in decidua during early 260 
pregnancy (5). Uterine NK cells are phenotypically and functionally quite 
distinct from NK cells circulating in peripheral blood and do express a range 
of receptors that can bind molecules expressed by placental cells (33,34). 
Of these, our focus has been on those receptors that could be involved in 
specific recognition of paternal difference (5,16). We have therefore 265 
studied NK receptors that can bind the MHC molecules expressed by EVT: 
HLA-C, -E and –G. The latter two are essentially monomorphic in human 
populations so will not vary from pregnancy to pregnancy (25). Uterine NK 
cells express Killer Immunoglobulin-like Receptors (KIR) that can recognize 
HLA-C, and invading trophoblast cells abundantly express both maternal and 270 
paternal HLA-C molecules (35).  However, the usual simple relationship 
between receptor and ligand is complicated by extreme polymorphism of 
both the KIR expressed by uNK and their trophoblast HLA-C ligands, with 
many different variants found within all populations.  This means that there 
is a range of possible interactions between variants of maternal KIR and 275 
alleles of fetal HLA-C ligands to which uNK cells bind.  Each pregnancy will 
thus bring together different combinations of maternal KIR and fetal HLA-C, 
with potentially different outcomes. 
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Killer Immunoglobulin-like Receptors (KIR) expressed by NK cells 280 
The KIR gene family is complex with a wide range in both the number of KIR 
genes inherited by the mother as well as allelic variation of individual KIR 
genes (36). Up to 14 different KIR genes are present in a linear array in the 
Leucocyte Receptor Complex (LRC) on chromosome 19q13.4. KIR are major 
regulators of NK cell function with different KIR conferring either an 285 
inhibitory or activating signal to the NK cell. Their most important known 
ligands are HLA-C molecules.  KIR are named based on the number of 
extracellular Ig-like domains (2D or 3D) and whether they have a long or 
short cytoplasmic tail (eg KIR2DL1 or KIR2DS1). Binding of KIR with a long 
cytoplasmic tail to their cognate ligands results in transduction of an 290 
inhibitory signal, whereas ligation of KIR with a short tail results in 
activation of NK cells. This complexity has been simplified by the clear 
distinction between two KIR haplotypes, A and B.  The KIR A haplotype is 
the most common and contains six inhibitory genes in most individuals.  The 
KIR B haplotype is much more variable in gene content and many of the 295 
additional KIR are activating.  An individual’s KIR genotype can thus be 
designated ‘AA’ ‘AB’ or ‘BB’ (Figure 2). Although there are over 1000 alleles 
of HLA-C, these can be distinguished by KIR as two distinct groups, HLA-C1 
and -C2, based on a dimorphism at position 80 of the 1 domain of the HLA-
C molecule (36). To date there is evidence that five members of the KIR 300 
family are capable of binding to HLA-C allotypes. The known KIR 
specificities for HLA-C are shown in Figure 2.  The strongest and most 
specific binding is of KIR2DL1 to HLA-C2 allotypes resulting in a strong 
inhibitory signal to NK cells. 
 305 
Combinations of maternal KIR and paternal HLA-C genotypes regulate 
birth weight 
To discover how this great polymorphism of maternal KIR and fetal HLA-C 
genes affects human reproductive success we have studied pregnancies 
where the KIR genotype of the mother and HLA-C group of her fetus is 310 
known.  Our results show that there is a consistent relationship between 
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particular combinations of maternal KIR and fetal HLA-C ligands and birth 
weight (3,35,37,38).  We compared maternal KIR and fetal HLA-C genotypes 
from a large number of first pregnancies selected from the Norwegian 
Mother-Baby cohort (MoBa) with known birth weight corrected for 315 
gestational age and fetal sex. A HLA-C2 group in the fetus is associated with 
pregnancies at the two extremes of birth weight especially when the HLA-C2 
allele is inherited from the father rather than the mother (3).  If the mother 
has two KIR A haplotypes (KIR AA genotype), then she will have inherited 
two copies of the inhibitory KIR for HLA-C2 allotypes, namely KIR2DL1. 320 
Functionally, when uNK cells from a KIR AA woman bind trophoblast 
expressing a paternal HLA-C2 allotype this results in a strong inhibitory 
signal. In contrast, high birth weight pregnancies are associated with a 
paternally-derived HLA-C2 allele, when the mother has inherited the 
activating KIR for HLA-C2, KIR2DS1 that is located on the KIR B haplotype (3).  325 
This effect is quite significant; the average increase in birth weight in 
pregnancies with a fetus with paternal HLA-C2 and KIR2DS1 in the mother is 
~200g, more than the differences found with sex of the baby (~50g) and high 
altitude (100g/1000 metres).  
 330 
This immune interaction is not comparable to other situations such as organ 
transplantation where there is clear self/non-self discrimination because it 
is only HLA-C alleles carrying the C2 epitope that confer any effect. To date, 
in pregnancies where the fetus is homozygous for HLA-C1 there is no 
influence of any KIR genotype on any clinical outcome in pregnancy that we 335 
have studied.  This may be due to the tight specificity and strong inhibition 
conferred by KIR2DL1/HLA-C2 interactions compared to the weaker and 
more promiscuous KIR2DL2/3 interactions with HLA-C molecules (39).  To 
summarize, at the site of placentation all the influences of HLA-C in 
pregnancy are mediated by paternal HLA-C2 with the maternal KIR genotype 340 
determining the outcome (high or low birth weight). In pregnancies where 
the fetus is homozygous for HLA-C1, then the effect of the maternal KIR is 
neutral and no associations are seen (3,35). 
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Functions of uNK cells during placentation 345 
The functional effects mediated by uNK cells at the uterine/placental 
interface relating to these different KIR/HLA-C combinations are hard to 
determine given the ethical and logistical problems of studying the site of 
placentation in early pregnancy in humans.  The great disparity in placental 
strategies in different species also means animal models are generally 350 
uninformative.  Furthermore, KIR genes are only a feature of simian 
primates, but even in these species there are fundamental differences in 
placentation with interstitial trophoblast invasion only a feature of the 
great apes (11).  A further major difficulty has been the lack of any 
reproducible and reliable in vitro model systems to study human trophoblast 355 
function in vitro. Nonetheless, uterine NK cells can be isolated and, despite 
their name, are poorly cytotoxic (40,41).  The input NK cells receive from 
KIR is either activating or inhibitory and NK function is a result of 
integrating this information and responding accordingly. When uterine NK 
cells receive an overall activating signal in a woman with a KIR B haplotype 360 
containing KIR2DS1, the output of soluble mediators like chemokines and 
cytokines (eg GM-CSF) is increased after co-culture with target cells bearing 
HLA-C2 molecules. This supernatant containing GM-CSF stimulates 
trophoblast invasion and migration in vitro (42). In contrast, when uNK cells 
from KIR AA women who only have the inhibitory KIR2DL1 for HLA-C2 were 365 
ligated with HLA-C2, trophoblast migration was not stimulated. This 
suggests there is reduced cytokine output by uNK cells in a woman with a 
KIR AA genotype when the overall signal is inhibitory. Thus, women with too 
much uNK cell inhibition (KIR AA) or too much activation (KIR B haplotype 
with KIR2DS1 present) are more likely to have babies with low or high birth 370 
weight respectively, when their uNK cells encounter trophoblast cells 
displaying a paternal HLA-C2 allotype.   The interpretation we have made 
based on the genetic and functional evidence is that the overall uNK 
response determines how far the trophoblast moves into the uterus and 
modifies the arteries (Figure 3). Thus, there is a direct link between the 375 
function of the uterine immune system and the birth weight of the baby. 
This specialized immune interaction may be essential to maintain the fetal 
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maternal interface within the strict limits dictated by the Obstetric 
Dilemma. 
 380 
Uterine NK cells also occur in the decidua in mice and appear to play an 
important role in vascular remodeling during placentation. Murine 
trophoblast invades into the decidua to a lesser degree than in humans and 
does not express non-classical MHC, so there are significant differences 
compared to human trophoblast (30). Although the major murine NK 385 
receptors that recognize MHC are the Ly49 family of receptors, they appear 
to function analogously to the human KIR. Mouse studies in which a single 
additional MHC molecule H2-Dd was introduced, showed impaired vascular 
remodeling and reduced fetal growth compared with identical mice lacking 
only H2-Dd (43). This MHC molecule binds the inhibitory receptor Ly49A and 390 
can inhibit additional uNK subsets when present. Particularly notable was 
the fact that reduced fetal growth was seen regardless of the parental 
origin of the H2-Dd molecule. These results confirm the idea that certain 
combinations of maternal NK receptors and paternal (or maternal) MHC 
molecules can influence trophoblast invasion and vascular remodeling.  In 395 
both human and murine pregnancies, excessive inhibition of NK cell function 
is associated with reduced fetal growth.  
 
Variation of KIR and HLA-C genes affects other diseases of pregnancy 
There is other independent evidence that will substantiate this model in 400 
humans. In common with low birth weight, obstetric syndromes such as pre-
eclampsia, and recurrent miscarriage are associated with reduced uterine 
invasion by trophoblast (44). Mothers at highest risk of these diseases are 
homozygous for the KIR A haplotype, and carry a fetus that has inherited 
HLA-C2 from the father (35,37,38). Women with a HLA-C2 fetus are 405 
protected from these disorders by the KIR B haplotype that contributes to 
protection in two possible ways. Firstly, many KIR B haplotypes include the 
activating KIR2DS1 that enhances trophoblast migration through enhanced 
secretion of ‘pro-invasion’ cytokines as described above. Secondly, the 
commonest KIR2DL1 allele on the B haplotype is KIR2DL1*004. This binds 410 
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more weakly to HLA-C2 than KIR2DL1*003, the most common allele on the A 
haplotype (45). We predict that there would be reduced inhibition of uNK 
cells by KIR2DL1*004 on the KIR B haplotype. The fact that diverse GOS with 
a common underlying pathology of reduced trophoblast invasion, also 
exhibit a similar KIR/HLA-C risk profile, supports the idea that 415 
uNK/trophoblast interactions play an important role in all these pregnancy 
disorders. 
 
If KIR AA and HLA-C2 combinations are significantly disadvantageous in 
pregnancy, this raises the question as to why they have not been eliminated 420 
from human populations by natural selection. All populations have both KIR 
A and KIR B haplotypes and HLA-C alleles with both C1 and C2 epitopes, 
suggesting that a balance of KIR A and B haplotypes and their ligands is 
essential for the survival of a community (46). However different 
populations across the world have different frequencies of KIR AA genotypes 425 
and HLA-C2 alleles.  Evidence that there is strong selective pressure from 
reproduction comes from the inverse correlation between KIR AA and HLA-
C2 frequencies (37,47). 
 
Pregnancy in African women 430 
There are a few populations that do not fit this picture as they have high 
frequencies of both KIR AA genotypes and HLA-C2 alleles.  Notably these are 
all found in sub-Saharan Africa where high HLA-C2 frequencies are 
characteristic. Sub-Saharan Africa is especially important in consideration of 
reproduction and birth, as maternal mortality rates are the highest in the 435 
world.  Figures of 600/100,000 births compared with only ~15 in high-
income countries mean this is one of the most extreme disparities in any 
health outcome (48,49).  Obviously poverty and lack of access to medical 
care are major problems but there are several indications that pregnancy 
and parturition in women from sub-Saharan Africa have many different 440 
features compared with women in other parts of the world (50).  Indeed, it 
appears that the Obstetric Dilemma is more of a problem for African women.  
Although there are no reliable records from Africa itself, studies of women 
Page 14 of 27
http://mc.manuscriptcentral.com/issue-ptrsb
Submitted to Phil. Trans. R. Soc. B - Issue
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
 15
of recent African ancestry in Europe and the Americas all indicate that all 
the GOS (pre-eclampsia, stillbirth, FGR and prematurity) occur more 445 
commonly as would be predicted by the high prevalence of HLA-C2 
combined with KIR AA genotypes in these African populations (51). One 
explanation for maintenance of these ‘reproductively risky’ genotypes is the 
observation that an individual’s resistance to infections such as hepatitis C 
virus is correlated with a KIR AA genotype and HLA-C1 (52). A simple model 450 
would be that human populations must maintain the KIR A haplotype and 
HLA-C1 in order to ensure resistance to pathogens. In contrast, reproductive 
success and the development of the larger human brain and more robust 
progeny are dependent on maintenance of KIR B haplotypes and HLA-C2. In 
each human population the relative frequencies of these haplotypes will be 455 
subject to natural selection depending on pathogen load, reproductive 
pressure and of course will change of time (12). The fact that all human 
populations maintain both KIR A and B haplotypes as well as HLA-C1 and –C2, 
suggests that populations that lose one of these components are doomed to 
extinction when subjected to extreme selection by events such as infection, 460 
famine and warfare.  
 
While the factors responsible for the high incidence of HLA-C2 and the KIR A 
haplotype in current African populations are not yet clear, this undoubtedly 
contributes to the high frequency of pre-eclampsia, stillbirth and fetal 465 
growth restriction found in sub-Saharan Africa. It is interesting to note that 
in such populations there is also an increased frequency of obstructed 
labour (50). This may be connected to the bony pelvis as measurements 
obtained by pelvimetry indicate that in African women some aspects of the 
birth canal are smaller (53). A high frequency of HLA-C2 and the KIR A 470 
haplotype may therefore reflect selection to reduce the birth weight but 
this will also result in an increased risk of the GOS.   In keeping with this, 
the development of the fetal organs is accelerated and the gestational age 
is shorter at 38 compared to 40 weeks (50,54). This clearly illustrates how 
the complex selective pressures acting on the evolution of the KIR/HLA-C 475 
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system could regulate human reproductive fitness, brain size, pathogen 
resistance and even the rate of fetal development.  
 
Conclusion 
The adaptations of the pelvis associated with bipedlaism coupled with the 480 
larger human brain, severely limit human birth weight. Conversely neonatal 
survival of smaller babies is greatly reduced. Human birth weight is thus 
subject to stabilizing selection. Although the control of birth weight is 
complex, adequate placentation to permit access to nutrients in maternal 
blood is essential for normal fetal growth. In humans this is achieved by 485 
trophoblast cells, which remodel maternal spiral arteries. Inadequate 
trophoblast invasion is associated with obstetric syndromes including pre-
eclampsia, recurrent miscarriage and FGR. We have shown that recognition 
of HLA-C on invading trophoblast by KIR receptors on maternal uNK plays a 
role in controlling trophoblast invasion and hence birth weight. Because 490 
both KIR and HLA-C genes are highly polymorphic, each pregnancy will bring 
together different combinations of maternal activating or inhibitory KIR that 
can recognize fetal HLA-C. Our findings suggest that binding of strongly 
inhibitory KIR to HLA-C2 expressed on trophoblast is detrimental to 
placentation. This combination is found more frequently in small babies. 495 
The presence of maternal activating receptor KIR2DS1 together with fetal 
HLA-C2 is associated with increased birth weight, suggesting the activation 
of uNK favours placentation. The association is strongest when a fetal HLA-
C2 allele is inherited from the father. These findings suggest that a balance 
of maternal activating and inhibitory KIR and HLA-C2 genotype frequencies 500 
act to maintain birth weight at an optimum for maternal and fetal survival.  
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 515 
 
 
 
Figure Legends 
 520 
Figure 1.  
Fetal growth restriction is associated with reduced remodelling of maternal 
spiral arteries by trophoblast cells. In normal pregnancy (right hand panel), 
extravillous trophoblast cells migrate as far as the myometrium and also 
infiltrate into the arterial media and endothelium of maternal spiral arteries. 525 
This results in dilatation and increased flow of maternal blood at low 
pressure into the intervillous space (red arrow). In pregnancies affected by 
pre-eclampsia or FGR (left panel), the depth of trophoblast invasion is 
reduced with less spiral artery remodelling. Blood flows at higher pressure 
and is more pulsatile, resulting in placental stress, reduced placental 530 
development and poor fetal growth.  
(Figure adapted from Moffett-King, 2002, reference 5, with permission).  
 
Figure 2. 
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Representative KIR A and B haplotypes of the KIR gene family, together with 535 
their known HLA-C binding specificities (C1 and C2) depicted above their 
cognate KIR receptors. KIR2DS4 binds a limited number of C1 and C2 
allotypes. Activating KIR are shown as blue boxes, inhibitory KIR are shown 
in red. Framework KIR genes that are present in all haplotypes are shown in 
black. Note many of the KIR shown on the B haplotype are not present in all 540 
individuals. 
 
Figure 3.  
Presence of maternal KIR2DS1 is associated with increased birth weight.  
A. Distribution of birth weights in the Norwegian MoBa cohort correlates 545 
with increased neonatal morbidity (frequency of transfer to special care 
baby unit) at the extremes of birth weight (3). The cohort was divided into 
low (<5th centile) normal (6-89th centile) and high (>90th centile) birth 
weight babies. The frequency of maternal KIR AA genotype + fetal HLA-C2 is 
increased in the small babies. Presence of maternal KIR2DS1 and fetal HLA-550 
C2 is associated with increased birth weight.  
B. Proposed model for maternal KIR/fetal HLA-C interactions at the site of 
placentation. In this model the fetus has inherited a paternal HLA-C2 allele 
and is homozygous for HLA-C2. If the mother has a KIR AA genotype, then 
KIR2DL1 binds strongly to trophoblast HLA-C2 molecules resulting in strong 555 
inhibition of uNK cells. This is associated with defective placentation. In 
contrast, when the mother has a KIR AB or BB genotype, the KIR2DL1 alleles 
on the B haplotype tend to inhibit uNK function more weakly when they bind 
C2.  The KIR B haplotypes also contain the activating KIR2DS1.  In this 
situation uNK cells are stimulated to produce increased levels of cytokines 560 
such as GM-CSF that can enhance placentation.  
 
 
 
 565 
  
 
 
 
570 
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